CDK4 and cancer: Given its central role in cell division control, it is not surprising that the cyclin D-CDK4/6 complex is often hyperactivated in many cancer entities, e.g., by gene amplification or point mutations, and drives oncogenic cell proliferation.4,5 Nonetheless, the mechanism of cyclin D degradation remained a matter of debate.